Computer Aided Drug Design, 3D Printing, and Virtual Screening: Recent Advancement and Applications in the Pharma Field

Abstract

Drug discovery in pharmaceutical research is a very time taking process. It takes around about 10 to 14 years reached to clinical trial. Chances of discovery of novel molecule reached to clinical trial are very less. Also, it takes billion of investment. Biomedical engineering with new technologies is the answer to these problems. The purpose of this review is to focus on the applications of new technologies like computer-aided drug design, virtual screening, molecular docking, 3D printing, etc. in the field of pharmaceutical research, drug delivery system, and drug discovery. So it is very important for all the researchers and pharmacy departments to be aware of the benefits or applications of these modern technologies. These modern technologies are very useful for pharmaceutical research including pharmacokinetics or pharmacodynamics modeling, optimization of the drug dosage form, and drug delivery system. The current progress of docking-based virtual screening leads to finding out the new target molecule and designing the molecule by using computer-aided drug design and ultimately manufacturing or customization of the dosage form by using 3D printing may finally lead to the become a reality.

Low-Data Drug Design with Few-Shot Generative Domain Adaptation

“…However, drug discovery is a long-term, high-investment, and high-risk endeavor that traditionally relies on human expertise to design, synthesize, and test new drug molecules [ 2 , 3 ]. Traditional drug design methods can take an average of 6 to 12 years and cost billions of dollars to produce just one drug [ 4 , 5 ]. While only an estimated compounds have ever been synthesized, the theoretical number of feasible compounds ranges from to [ 6 ].…”